US › Healthcare

enGene Holdings Inc. Common Stock (ENGN)

US · Healthcare · Biotechnology

$1.79+1.13%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$0
Net profit
$30.2M
Profit YoY
+217.1%
EPS
$-0.43
EPS estimate
$-0.48

EPS came in at -0.43 against a street estimate of -0.48 — a beat of 10.4%.

Key statistics

Market cap
$119.9M
Forward P/E
0.0
P/B
0.47
Book value
$3.81
EPS (TTM)
$-2.18
52-week high
$12.25
52-week low
$1.40
50-day MA
$1.77
200-day MA
$6.39
Beta
-0.28

Analyst view

Analysts rate enGene Holdings Inc. Common Stock a buy (9 buy, 1 hold, 0 sell out of 10) with an average price target of $3.29.

Shareholding

Insiders
0.10%
Institutions
106.88%

Largest institutional holders

FundStake
Siren, L.L.C.7.84%
Blue Owl Capital Holdings LP6.59%
Deep Track Capital, LP6.53%
BRAIDWELL LP3.67%
Nextech Invest, Ltd.3.47%
MPM Oncology Impact Management LP2.75%
Kynam Capital Management, LP2.03%
Franklin Resources Inc1.96%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for enGene Holdings Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.